Furthermore, the synergistic enhancement in cancer cell killing effect by oAd-vp53/APP complex was cancer-specific, since oAd-vp53/APP complex induced minimal level of cytotoxicity that was similar to PTX, oAd-vp53 + PTX, or APP treatment in several normal cell lines. This evidence concerns the gene APP and cancer.